NCT04946578

Brief Summary

The aim of this study is to investigate the effect of a six-week period personalised food intervention with prebiotic supplementation on intense exercise performance in healthy, recreationally active adults.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

July 1, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

May 5, 2021

Last Update Submit

June 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to Exhaustion

    Time on cycle ergometer until exhaustion

    From baseline to end of the study (up to max 45 days)

Secondary Outcomes (5)

  • Gut microbiota composition

    From baseline to end of the study (up to max 45 days)

  • Plasma short chain fatty acids

    From baseline to end of the study (up to max 45 days)

  • Blood glucose

    From baseline to end of the study (up to max 45 days)

  • Insulin

    From baseline to end of the study (up to max 45 days)

  • Intestinal permeability by sugar test

    From baseline to end of the study (up to max 45 days)

Study Arms (2)

Prebiotic intervention group

EXPERIMENTAL

Prebiotic supplementation

Dietary Supplement: Prebiotic

Placebo control group

PLACEBO COMPARATOR

Maltodextrin

Other: Placebo

Interventions

PrebioticDIETARY_SUPPLEMENT

6 weeks of prebiotic supplementation twice a day

Prebiotic intervention group
PlaceboOTHER

6 weeks of maltodextrin supplementation twice a day

Placebo control group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female 18 - 40 y
  • BMI range 18.5 - 25 kg/m2
  • Recreational active (performing non-competitive physical endurance exercise at least two times per week with a minimum duration of 60 minutes per exercise bout)

You may not qualify if:

  • Smoking
  • Performing regular resistance training (3+ times per week, carrying out progressive overload training)
  • Subject following an overly imbalanced or restrictive diet as per nutritional advice
  • Participants who received antibiotics in the 90 days prior to the start of the study
  • Self-admitted lactose intolerance
  • Administration of probiotic or prebiotic supplements in the 14 days prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, Limburg, Netherlands

RECRUITING

MeSH Terms

Conditions

Congenital Microtia

Interventions

Prebiotics

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Dietary FiberDietary CarbohydratesCarbohydratesPolysaccharides, BacterialPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaDietary SupplementsFood and Beverages

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study conforms to a randomized, single-blinded, placebo-controlled parallel study design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 5, 2021

First Posted

July 1, 2021

Study Start

August 24, 2020

Primary Completion

August 23, 2021

Study Completion

September 30, 2021

Last Updated

July 1, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations